ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Connecticut » Pulmonary Disease

Top Pulmonary Disease Prescribers in Connecticut

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
DEBAPRIYA DATTA M.D.

Pulmonary Disease

465

$88.8K

65
40 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

79%
prescriptions for brand name drugs

Avg: 64%

$191
Average prescription price

Avg: $170

JENNIFER POSSICK M.D.

Pulmonary Disease

459

$60.2K

105
74 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

64%
prescriptions for brand name drugs

Avg: 64%

$131
Average prescription price

Avg: $170

SAMER MORCOS MD

Pulmonary Disease

452

$76.8K

95
80 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

64%
prescriptions for brand name drugs

Avg: 64%

$170
Average prescription price

Avg: $170

MARK SIEGEL MD

Pulmonary Disease

448

$86K

37
19 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

53%
prescriptions for brand name drugs

Avg: 64%

$192
Average prescription price

Avg: $170

MOLLY HOLT

Pulmonary Disease

435

$82.1K

133
112 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

68%
prescriptions for brand name drugs

Avg: 64%

$189
Average prescription price

Avg: $170

STASIA WIEBER MD

Pulmonary Disease

359

$44.9K

64
51 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

52%
prescriptions for brand name drugs

Avg: 64%

$125
Average prescription price

Avg: $170

SHAILESH PINTO MD

Pulmonary Disease

358

$102K

61
44 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

75%
prescriptions for brand name drugs

Avg: 64%

$285
Average prescription price

Avg: $170

DANIEL MCNALLY MD

Pulmonary Disease

342

$146K

48
35 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

62%
prescriptions for brand name drugs

Avg: 64%

$428
Average prescription price

Avg: $170

STEPHEN WINTER MD

Pulmonary Disease

338

$67.1K

45
43 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

75%
prescriptions for brand name drugs

Avg: 64%

$199
Average prescription price

Avg: $170

LAUREN COHN MD

Pulmonary Disease

298

$50.5K

38
19 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

76%
prescriptions for brand name drugs

Avg: 64%

$170
Average prescription price

Avg: $170

PRASHANT GROVER M.D.

Pulmonary Disease

291

$58.8K

49
35 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

74%
prescriptions for brand name drugs

Avg: 64%

$202
Average prescription price

Avg: $170

ERNEST MORITZ MD

Pulmonary Disease

287

$48.1K

36
34 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

60%
prescriptions for brand name drugs

Avg: 64%

$168
Average prescription price

Avg: $170

DANIELLE ANTIN-OZERKIS MD

Pulmonary Disease

284

$18.8K

28
17 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 64%

$66
Average prescription price

Avg: $170

JO-ANNE COSGRIFF MD

Pulmonary Disease

269

$51.1K

38
30 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

79%
prescriptions for brand name drugs

Avg: 64%

$190
Average prescription price

Avg: $170

NAUSHERWAN BURKI MD

Pulmonary Disease

181

$39.3K

25
18 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

98%
prescriptions for brand name drugs

Avg: 64%

$217
Average prescription price

Avg: $170

LESTER KRASNOGOR M.D.

Pulmonary Disease

157

$29.5K

26
22 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

94%
prescriptions for brand name drugs

Avg: 64%

$188
Average prescription price

Avg: $170

MARGARET PISANI MD

Pulmonary Disease

134

$22.2K

14
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

82%
prescriptions for brand name drugs

Avg: 64%

$165
Average prescription price

Avg: $170

PAUL NOBLE MD

Pulmonary Disease

127

$7,282

19
13 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 64%

$57
Average prescription price

Avg: $170

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank